ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,795Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 337

$497K Total Retail Price of All Prescriptions

Rank: 78 out of 337

476 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,613 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LEVOTHYROXINE SODIUM 581 479 1 5
OMEPRAZOLE 465 274 2 4
SIMVASTATIN 429 313 3 1
AMLODIPINE BESYLATE 375 311 4 3
LISINOPRIL 338 272 5 2
HYDROCODONE-ACETAMINOPHEN 319 221 S3 6 13
METOPROLOL TARTRATE 317 247 7 6
WARFARIN SODIUM 308 295 8 11
LOVASTATIN 282 186 9 24
TRAZODONE HCL 268 233 10 16
SERTRALINE HCL 232 177 11 18
CITALOPRAM HBR 219 135 12 17
HYDROCHLOROTHIAZIDE 216 144 13 9
FUROSEMIDE 209 198 14 8
ATORVASTATIN CALCIUM 207 187 15 7
ATENOLOL 192 137 16 10
ALENDRONATE SODIUM 150 112 17 19
DONEPEZIL HCL 149 143 18 22
PAROXETINE HCL 144 105 19 46
TRAMADOL HCL 134 122 20 32
MIRTAZAPINE 111 110 21 27
QUETIAPINE FUMARATE 111 70 21 61
SINGULAIR 105 75 23 113
AZITHROMYCIN 104 81 24 51
LOSARTAN POTASSIUM 100 82 25 15
NAMENDA 99 88 26 35
PRAVASTATIN SODIUM 97 67 27 14
BUSPIRONE HCL 94 57 28 129
TRIAMTERENE-HCTZ 89 52 29 39
GABAPENTIN 82 68 30 20
LIPITOR 81 64 31 33
FLUTICASONE PROPIONATE 81 13 31 34
CIPROFLOXACIN HCL 80 71 33 71
METFORMIN HCL 79 51 34 12
RANITIDINE HCL 76 58 35 30
PROAIR HFA 75 16 36 38
PANTOPRAZOLE SODIUM 72 69 37 36
DIOVAN 68 68 38 26
ZOLPIDEM TARTRATE 66 45 39 23
GLIPIZIDE ER 63 61 40 69
MONTELUKAST SODIUM 62 42 41 206
DIGOXIN 61 61 42 58
METOPROLOL SUCCINATE 60 39 43 21
TOPIRAMATE 60 0 43 228
GLIPIZIDE 59 44 45 45
OXYCONTIN 59 15 S2 45 87
ALLOPURINOL 59 46 45 28
QUINAPRIL HCL 57 53 48 50
OXYBUTYNIN CHLORIDE ER 56 17 49 124
ADVAIR DISKUS 55 43 50 44
TAMSULOSIN HCL 54 54 51 25
CRESTOR 52 47 52 29
LOSARTAN-HYDROCHLOROTHIAZIDE 52 42 52 60
CARBIDOPA-LEVODOPA 50 50 54 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.